Form 4 for QNCX Quince Therapeutics, Inc.

Accepted 2023-08-31 00:00:00 ET · period of report 2023-08-30 · accession 0001209191-23-047880 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2023-08-31	2023-08-30+	QNCX	Lamond David	Dir	P - Purchase	$1.31	+82.1K	2.14M	+4%	+$107.9K

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2023-08-31	P	A	41,026	$1.32	2,179,161	I By Blue Devil Trust dated 12/03/2010	—	—	(F3) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.29 to $1.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F2) Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.
2	Common	Common Stock	2023-08-30	P	A	41,026	$1.31	2,138,135	I By Blue Devil Trust dated 12/03/2010	—	—	(F1) The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.30 to $1.32, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. (F2) Mr. Lamond is the trustee of Blue Devil Trust dated 12/03/2010 (the "Trust") and holds sole voting and dispositive power with respect to the shares held of record by the Trust.